Avrupa Birliği - Fince - EMA (European Medicines Agency)

theramex ireland limited - linzagolix choline - leiomyoma - aivolisäkkeen ja hypotalamuksen hormonit ja analogit - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Avrupa Birliği - Fince - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolaktoni - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.

Avrupa Birliği - Fince - EMA (European Medicines Agency)

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiset aineet - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Avrupa Birliği - Fince - EMA (European Medicines Agency)

orion corporation - levodopa, karbidopa, entakaponi - parkinsonin tauti - parkinson-lääkkeet - corbilta on tarkoitettu hoito aikuispotilailla, joilla on parkinsonin tauti ja lopulta annoksen motor vaihtelut ole vakaa levodopa/dopa dekarboksylaasin (ddc) estäjä hoitoa.

Avrupa Birliği - Fince - EMA (European Medicines Agency)

orion corporation - levodopa, karbidopa, entakaponi - parkinsonin tauti - hermosto - levodopa, carbidopa, entacapone orion on tarkoitettu hoito aikuispotilailla, joilla on parkinsonin tauti ja lopulta annoksen motor vaihtelut ole vakaa levodopa / dopa-dekarboksylaasin (ddc)-estäjä hoitoa.

Avrupa Birliği - Fince - EMA (European Medicines Agency)

orion corporation - levodopa, karbidopa, entakaponi - parkinsonin tauti - parkinson-lääkkeet - stalevo on tarkoitettu hoidettaessa aikuispotilailla, joilla on parkinsonin tauti ja annoksen lopussa olevat moottorin heilahtelut, joita ei ole stabiloitu levodopa / dopa-dekarboksylaasi (ddc) -inhibitorin hoitoon.

Finlandiya - Fince - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, entacapone, levodopa - tabletti, kalvopäällysteinen - 50 mg / 12,5 mg / 200 mg - levodopa

Finlandiya - Fince - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, levodopa, entacapone - tabletti, kalvopäällysteinen - 75 mg / 18,75 mg / 200 mg - levodopa

Finlandiya - Fince - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, entacapone, levodopa - tabletti, kalvopäällysteinen - 100 mg / 25 mg / 200 mg - levodopa

Finlandiya - Fince - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, levodopa, entacapone - tabletti, kalvopäällysteinen - 125 mg / 31,25 mg / 200 mg - levodopa